# Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs

> **NCT01081561** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Yaron S. Rabinowitz M.D.** · enrollment: 600 (estimated)

## Conditions studied

- Keratoconus
- Ectasia

## Interventions

- **DRUG:** Riboflavin

## Key facts

- **NCT ID:** NCT01081561
- **Lead sponsor:** Yaron S. Rabinowitz M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01-21
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081561, "Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01081561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*